Noncovalent Binding to DNA: Still a Target in Developing Anticancer Agents

Publisher： Bentham Science Publishers

E-ISSN： 1875-533x|23|36|4108-4134

ISSN： 0929-8673

Source： Current Medicinal Chemistry, Vol.23, Iss.36, 2016-11, pp. : 4108-4134

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Microtubulin Binding Sites as Target for Developing Anticancer Agents

By  

Mini Reviews in Medicinal Chemistry, Vol. 4, Iss. 10, 2004-12 ,pp. : 1077-1104

Bentham Science Publishers

Access to resources Recommend Favorite

DNA: Still A Target Worth Aiming At?: A Review of New DNA-Interactive Agents

By Anthoney D.A.   Twelves C.J.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 1, 2001-01 ,pp. : 67-81

Adis International

Access to resources Recommend Favorite

DNA minor groove binding ligands: a new class of anticancer agents

By D'Incalci M.   Sessa C.  

Expert Opinion on Investigational Drugs, Vol. 6, Iss. 7, 1997-07 ,pp. : 875-885

Informa Healthcare

Access to resources Recommend Favorite

DNA-Binding Properties of Poly(ADP-Ribose) Polymerase: A Target for Anti-Cancer Therapy

By  

Current Drug Targets, Vol. 5, Iss. 4, 2004-05 ,pp. : 357-365

Bentham Science Publishers

Access to resources Recommend Favorite

Synthesis of Benzopyran Linked Pyrrolo[2,1-c][1,4]benzodiazepines as DNA-Binding and Potential Anticancer Agents

By  

Medicinal Chemistry, Vol. 9, Iss. 2, 2013-03 ,pp. : 177-192

Bentham Science Publishers

Access to resources Recommend Favorite